19 November 2024

READ MOREPurdue University and Akston Biosciences Bring “First Dose of Hope” in New Cancer Immunotherapy Trial for Dogs with Urinary Bladder Cancer

20 August 2024

READ MOREEnergesis and Akston Biosciences Sign Partnership Agreement for Companion Animal Obesity Drug Development

13 August 2024

READ MOREPurdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development

30 July 2024

READ MOREDechra Purchases Veterinary Insulin Programs from Akston Biosciences

17 June 2024

READ MOREDr. Linda Rhodes Joins Akston Biosciences’ Board of Directors

11 March 2024

READ MOREAkston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility

26 February 2024

READ MOREAkston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility

31 August 2023

READ MOREAkston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit

28 August 2023

READ MOREAkston Biosciences CEO to Present at the 2023 Animal Health Summit in Kansas City

17 August 2023

READ MOREAkston Biosciences to Focus on Strong Animal Health Pipeline